三鑫医疗：收到深圳证券交易所审核问询函

Core Viewpoint - The company has received an inquiry letter from the Shenzhen Stock Exchange regarding its application to issue convertible bonds to unspecified investors, indicating a regulatory review process is underway [1] Group 1 - The company received the inquiry letter on November 14, 2025, from the Shenzhen Stock Exchange [1] - The inquiry pertains to the company's application documents for issuing convertible bonds [1] - The company, along with relevant intermediaries, has carefully studied the questions raised in the inquiry and has provided responses, along with supplementary and revised application documents [1]